The role of continuous renal replacement therapy in the future treatment of acute renal failure

American Journal of Kidney Diseases

Volumn 28, Issue 5 SUPPL. 3, 1996, Pages

  Conger, John D ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Continuous dialysis; dialysis membranes; growth factors; natriuretic peptides; oliguria; vasculature

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR AGENT; DIURETIC AGENT; DOPAMINE; GROWTH FACTOR; SOMATOMEDIN;

ACUTE KIDNEY FAILURE; ARTICLE; BRADYCARDIA; CATABOLISM; CLINICAL TRIAL; DIALYSIS MEMBRANE; DRUG THERAPY; HUMAN; HYPOTENSION; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; NUTRITION; OLIGURIA; PREDICTION; PROGNOSIS;

EID: 0029855175     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90089-X     Document Type: Article

References (70)

1. Vertel RM, Knochel JP: Non-oliguric acute renal failure. JAMA 200:118-122, 1967
2. Ireland GW, Cass AS: The recognition and management of acute high output renal failure. Medicine 108:40-45, 1972
3. Danovitch G, Carvounis C, Weinstein E, Levenson S: Nonoliguric acute renal failure. Isr J Med Sci 15:5-8, 1979
4. Brahman SAN, Conger JD: Glomerular and tubular factors in urine flow rate of acute renal failure patients. Am J Kidney Dis 23:788-793, 1994
5. Anderson RJ, Linas SL, Berns AS, Henrich WL, Miller TR, Gabow PA, Schrier RW: Nonoliguric acute renal failure. N Engl J Med 296:1134-1138, 1977
6. Dixon BS, Anderson RJ: Nonoliguric acute renal failure. Am J Kidney Dis 6:71-80, 1985
7. Frankel MC, Weinstein AM, Stenzel KH: Prognostic patterns in acute renal failure: The New York Hospital, 1981-1982. Clin Exp Dial Apheresis 7:145-167, 1983
8. Minuth AN, Terrell JB, Suki WN: Acute renal failure: A study of the course and prognosis of 104 patients and of the role of furosemide. Am J Med Sci 271:317-324, 1976
9. Swann RC, Merrill JP: The clinical course of acute renal failure. Medicine 32:215-293, 1953
10. Myers BD, Moran SM: Hemodynamically mediated acute renal failure. N Engl J Med 314:97-105, 1986
11. Rahman SN, Butt AR, DuBose TD, Marbury TC, Sweet RM, Weisberg L, Fenves AZ, Lafayette RA, Center FC, Allgren RL: Differential clinical effects of anaritide atrial natriuretic peptide (ANP) in oliguric and non-oliguric ATN. J Am Soc Nephol 6:474A, 1995 (abstr)
12. Lafayette RA, Allgren R: Baseline factors affecting outcome in acute tubular necrosis. J Am Soc Nephrol 6:469A, 1995 (abstr)
13. Chew SL, Lins RL, Daelemans R, De Broe ME: Outcome in acute renal failure. Nephrol Dial Transplant 7:230-234, 1992
14. Woodrow G, Turney JH: Cause of death in acute renal failure. Nephrol Dial Transplant 8:101-107, 1993
15. Bullock ML, Umen AJ, Finkelstein M, Keane WF: The assessment of risk factors in 462 patients with acute renal failure. Am J Kidney Dis 5:97-103, 1985
16. Hou SH, Bushinsky A, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficience: A prospective study. Am J Med 47:243-248, 1983
17. Kaufman J, Dhakal M, Patel B, Hamburger R: Community-acquired acute renal failure. Am J Kidney Dis 17:191-198, 1991
18. Horl W, Stepinski J, Schafer R, Nanner C, Heidland A: Role of proteases in hypercatabolic patients with renal failure. Kidney Int 24:537-542, 1983
19. Wesson DE, Mitch W, Wilmore D: Nutritional considerations in the treatment of acute renal failure, in Brenner B, Lazarus JM (eds): Acute Renal Failure. Philadelphia, PA, Saunders, 1983, pp 618-641
20. Feinstein EI, Blumenbrantz M, Healy M, Koffler A, Silberman H, Massry S, Kopple J: Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine 60:124-137, 1981
21. Sponsel H, Conger JD: Is aggressive nutritional therapy of value in acute renal failure patients? Am J Kidney Dis 25:96-102, 1995
22. Ding H, Kopple J, Cohen A, Hirschberg R: Recombinant human insulin-like growth factor-1 accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 91:2281-2287, 1993
23. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G: Risk factors and outcome of hospital acquired acute renal failure. Am J Med 83:65-71, 1987
24. Wilkins RG, Faragher EB: Acute renal failure in an intensive care unit. Anesthesia 38:628-634, 1983
25. Rasmussen HH, Pitt EA, Ibels LS, McNeil DR: Prediction of outcome in acute renal failure by discriminant analysis of clinical variables. Arch Intern Med 145:2015-2018, 1985
26. Lohr JW, McFarlane MJ, Grantham JJ: A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis 11:254-259, 1988
27. Cioffi WG, Ashikaga T, Gamelli RL: Probability of surviving postoperative acute renal failure. Ann Surg 200:205-211, 1984
28. Halstenberg N, Goormastic M, Paganini EP: Utility of risk models for renal failure and critically ill patients. Semin Nephrol 14:23-32, 1994
29. Sayegh MH, Chertow GM, Allgren RL, Lazarus JM: The need for dialysis in patients with severe acute renal failure: Influence of acute factors. J Am Soc Nephrol 6:476A, 1995 (abstr)
30. Cantarovich F: Discriminant clinical variables (cv) and outcome of established acute renal failure (ARF). J Am Soc Nephrol 5:389A, 1994 (abstr)
31. Roth DA, Zuniga O: A scorecard method for stratifying risk in critically ill patients with acute renal failure (ARF). J Am Soc Nephrol 6:475A, 1995 (abstr)
32. Ossenkoppele GJ, Van Der Muelen J, Bronsveld W, Thijs LG: Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 13:102-104, 1985
33. Schafer GE, Doring C, Sodemann K, Russ A, Schroder HM: Continuous arteriovenous and venovenous hemodialysis in critically ill patients. Contrib Nephrol 93:23-28, 1991
34. Bosworth C, Paganini EP, Cosentino F, Heyka RJ: Long-term experience with continuous renal replacement therapy in intensive-care unit acute renal failure. Contrib Nephrol 93:13-16, 1991
35. Kierdorf H: Continuous versus intermittent treatment: Clinical results in acute renal failure. Contrib Nephrol 93:1-12, 1991
36. McDonald BR, Mehta RL: Decreased mortality in patients with acute renal failure undergoing continuous arteriovenus hemodialysis. Contrib Nephrol 93:51-56, 1991
37. Silva H, Pomeroy J, Rae HI, Rosen SM, Shaldon S: Daily hemodialysis in "hypercatabolic" acute renal failure. Br Med J 2:407-410, 1964
38. Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D: Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int 15:1056-1063, 1975
39. Fischer RP, Griffin WO, Clark DS: Early dialysis in the treatment of acute renal failure. Surg Gynecol Obstet 123:1019-1023, 1966
40. Walsh A, O'Dwyer WF, Woodcock JA, Doyle G, Barry AP: Earlier dialysis in renal failure. Br J Urol 23:430-434, 1961
41. Conger JD: A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 15:1056-1063, 1975
42. Gillum DM, Falk SA, Hammond WS, Conger JD: Glomerular dynamics in the hypothyroid rat and the role of the renin-angiotensin system. Am J Physiol 22:F170-F179, 1987
43. Conger JD, Schultz MF, Miller F, Robinette JB: Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46:318-326, 1994
44. Kelleher SP, Robinette JB, Miller F, Conger JD: Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int 31:725-730, 1987
45. Manns M, Sigler MH, Teehan BP: Advantages of continuous veno-venous hemodialysis in acute renal failure. J Am Soc Nephrol 6:470A, 1995 (abstr)
46. Solez L, Marel-Maroger L, Sraer J: The morphology of acute tubular necrosis in man. Analysis of 57 renal biopsies and comparison with glycerol model. Medicine 58:362-376, 1979
47. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
48. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331:1338-1342, 1994
49. Stone AM, Stahl WM: Effects of ethacrynic acid and furosemide on renal function in hypovolemia. Ann Surg 174:1-8, 1971
50. Nuutinen LS, Kiraluoma M, Yuononen S, Larmi TKI: The effect of furosemide on renal function in open heart surgery. J Cardiovasc Surg 19:471-483, 1978
51. Cantarovich F, Locatelli A, Fernandez JC, Loredo JP, Christhot J: Furosemide in high doses in the treatment of acute renal failure. Postgrad Med J 47:13-18, 1971 (suppl)
52. Cantarovich F, Galli C, Benedetti L, Chena C, Castro L, Correa C, Loredo JP, Fernandez JC, Locatelli A, Tizado J: High dose furosemide in established acute renal failure. Br Med J 4:449-454, 1973
53. Kleinknecht D, Ganeval D, Gonalez-Duque LA, Fermanian J: Furosemide in acute oliguric renal failure: A controlled trial. Nephron 17:51-58, 1976
54. Brown CB, Ogg CS, Cameron JS: High dose furosemide in acute renal failure: A controlled trial. Clin Nephrol 15:90-95, 1986
55. Lindner A: Synergism of dopamine and furosemide in diuretic resistant, oliguric acute renal failure. Nephron 33:121-124, 1983
56. Graziani G, Casati S, Cantaluppi A, Citterio A, Scalamogna, Aroldi A, Silenzio R, Brancaccio D, Ponticelli C: Dopamine-furosemide therapy in acute renal failure. Proc Eur Dialysis Transplant Assoc 19:319-324, 1982
57. Lumlertgul D, Keopling M, Sitprija V, Moollaor P, Suwangool P: Furosemide and dopamine in malaria acute renal failure. Nephron 52:40-45, 1989
58. Conger JD: Drug therapy in acute renal failure, in Lazarus JM, Brenner BM (eds): Acute Renal Failure. New York, NY, Churchill Livingstone, 1993, pp 529-552
59. A receptor antagonist in the rat. J Clin Invest 93:900-906, 1994
60. Jumes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757-1761, 1989
61. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 34:F61-F69, 1993
62. Bergman AS, Falt K, Odar-Cederlof I, Westman L, Takolander R: Calcitonin gene-related peptide attenuates experimental ischemic renal failure in a rat model of reversible renal ischemic insult. Renal Fail 16:351-357, 1994
63. Miller SB, Hansen VA, Hammerman MR: Insulin-like growth factor 1 accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880, 1992
64. Hummel M, Kuhn M, Bub A, Bittner H, Kleefeld D, Marxen P, Schneider B, Hetzer R, Forssman WG: Urodilatin: A new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients. Clin Invest 70:674-682, 1992
65. Rahman SN, Kim GE, Mathew AS, Goldberg CA, Allgren R, Schrier RW, Conger JD: Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45:1731-1738, 1994
66. Marbury TC, Rahman SN, Sweet RM, Fenves AZ, Weisberg L, Lafayette RA, Genter FC, Allgren RL: A randomized, double-blind, placebo-controlled multi center clinical trial of anaritide atrial natriuretic peptide (ANP) in the treatment of ATN. J Am Soc Nephrol 6:470A, 1995 (abstr)
67. Tulassay T, Rascher W, Lang RE, Hannsjorg WS, Scharer K: Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. Kidney Int 31:1391-1395, 1987
68. Richards AM, Ikrah H, Yandle TG, Nicholls MG, Webster MWI, Espiner EA: Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1:545-548, 1985
69. Haylor J, Singh I, El Nahas AM: Nitric oxide synthesis inhibitor prevents vasolidation by insulin-like growth factor-1. Kidney Int 39:333-335, 1991
70. Guler HP, Eckardt KU, Kapf J, Bauer C, Froesch ER: Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 121:101-106, 1989